The Scientist

» clinical trials and microbiology

Most Recent

image: More Doubt Cast Over Cardiac Stem Cells

More Doubt Cast Over Cardiac Stem Cells

By | May 7, 2014

Contrary to previous reports, cell lineage tracing reveals stem cells in the heart rarely contribute to new muscle.

0 Comments

image: Hear Ye, Hear Ye

Hear Ye, Hear Ye

By | May 1, 2014

Tools for tracking quorum-sensing signals in bacterial colonies

2 Comments

image: The Telltale Tail

The Telltale Tail

By | May 1, 2014

A symbiotic relationship between squid and bacteria provides an alternative explanation for bacterial sheathed flagella.

0 Comments

image: Microbe’s Diversity Is Vast, Ancient

Microbe’s Diversity Is Vast, Ancient

By | April 24, 2014

A marine cyanobacterium possesses astounding genomic diversity, yet still organizes into distinct subpopulations that have likely persisted for ages.

0 Comments

image: Money Microbiome

Money Microbiome

By | April 24, 2014

Swabbing cash circulating in New York City reveals more than 3,000 different types of bacteria.

2 Comments

image: Microbiome Influences

Microbiome Influences

By | April 22, 2014

Researchers find that gender, education level, and breastfeeding can affect humans’ commensal microbial communities.

2 Comments

image: Opinion: Overcoming Cancer’s Complexities

Opinion: Overcoming Cancer’s Complexities

By , , and | April 11, 2014

Considering “targeted therapeutics” in the face of intra-patient heterogeneity. 

2 Comments

image: Updated Review: Tamiflu Is a Bust

Updated Review: Tamiflu Is a Bust

By | April 10, 2014

After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.

6 Comments

image: The Promise of Nanomedicine

The Promise of Nanomedicine

By | April 8, 2014

At AACR, scientists discuss the growing interest in nanotechnology and how it can be used to study, diagnose, and treat cancer.

0 Comments

image: Epigenetic Cancer Therapy Clears Phase I

Epigenetic Cancer Therapy Clears Phase I

By | April 7, 2014

Investigational drug that inhibits proteins involved with epigenetic regulation shows activity against certain blood cancers in an early-stage clinical trial.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Cannibalism: Not That Weird
    Reading Frames Cannibalism: Not That Weird

    Eating members of your own species might turn the stomach of the average human, but some animal species make a habit of dining on their own.

  4. Can Plants Learn to Associate Stimuli with Reward?
Business Birmingham